Sevoflurane and Propofol for Botulinum Toxin Injection
Status:
Not yet recruiting
Trial end date:
2026-02-28
Target enrollment:
Participant gender:
Summary
The investigators would like to compare clinical features (onset, duration, emergence time),
efficacy of deep sedation (successful completion of procedure), safety (adverse events) and
caregiver's satisfaction for sedation when used propofol and sevoluflurane for deep sedation
in 3-11 year old pediatric patients with spastic cerebral palsy receiving botulinum toxin
injection.